Evaluating the pharmacotherapy of tirzepatide in patients with type 2 diabetes: The consideration of systemic metabolism-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Evaluating the pharmacotherapy of tirzepatide in patients with type 2 diabetes: The consideration of systemic metabolism

Published:2022-12-27 Issue:3 Volume:89 Page:1222-1223
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Brit J Clinical Pharma

Author:

Lee Yu‐Cheng¹,Chung Hsien‐Hui²³⁴^ORCID

Affiliation:

1. Graduate Institute of Medical Sciences, College of Medicine Taipei Medical University Taipei City Taiwan

2. Department of Pharmacy & Clinical Trial Pharmacy Kaohsiung Veterans General Hospital Kaohsiung City Taiwan

3. Preventive Medicine Program, Center for General Education Chung Yuan Christian University Taoyuan City Taiwan

4. Department of Pharmacy and Master Program, College of Pharmacy and Health Care Tajen University Pingtung County Taiwan

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.15630

Reference10 articles.

1. One hundred years since insulin discovery: An update on current and future perspectives for pharmacotherapy of diabetes mellitus

2. Efficacy of tirzepatide 5, 10 and 15 mg versus semaglutide 2 mg in patients with type 2 diabetes: An adjusted indirect treatment comparison

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP